Abbott Laboratories declares $0.45 dividend
- BySeeking Alpha-
Abbott Laboratories (NYSE:ABT) declares $0.45/share quarterly dividend, in line with previous.Forward yield 1.64%Payable Aug.
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abbott Laboratories (ABT)
93.92
-0.04(-0.04%)
- Volume:25
- Bid/Ask:0.00/0.00
- Day's Range:93.58 - 93.92
ABT Overview
- Prev. Close
- 93.96
- Day's Range
- 93.58-93.92
- Revenue
- -
- Open
- 93.58
- 52 wk Range
- 76.83-107.14
- EPS
- -
- Volume
- 25
- Market Cap
- 165.97B
- Dividend (Yield)
- 1.49(1.64%)
- Average Vol. (3m)
- 369
- P/E Ratio
- -
- Beta
- -
- 1-Year Change
- 15.46%
- Shares Outstanding
- -
- Next Earnings Date
- Jul 21, 2021
What is your sentiment on Abbott Laboratories?
or
Vote to see community's results!
Abbott Laboratories News
- 3 Must-Own Healthcare Stocks for June
- ByStockNews-
Despite the healthcare system’s limitations having been exposed last year amid the COVID-19 pandemic, investors’ interest in the industry has been growing due to the...
- Raymond James Stick to Their Buy Rating for Abbott Labs
- ByInvesting.com-
Raymond James analyst Jayson Bedford maintained a Buy rating on Abbott Labs on Tuesday, setting a price target of $116, which is approximately 9.65% above the present share price...
Abbott Laboratories Analysis
- This 5-Stock Healthcare Portfolio Yields 5.5%
Healthcare—along with consumer staples (“buying stuff”) and utilities (“keeping the lights on”)—provide portfolio stability. Plus, they usually...
- As Vaccines Roll Out, Here’s A Health-Care ETF To Watch In Second Half Of 2021
Healthcare, especially vaccine development and rollout efforts, has become one of the most widely-followed topics during the pandemic. And due to the pandemic, a large number of...
- Abbott (ABT) Confirms Capacity to Support MCS Devices Demand
Abbott Laboratories (NYSE:ABT) ABT recently confirmed that it has adequate capacity and supply to support the expanded use of HeartMate3 heart pump to meet the rising demand for...
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 62.72 | 64.95 | 60.67 | +1.99 | +3.28% | 88.16M | NYSE | |||
| 2,413.05 | 2,430.99 | 2,408.00 | -21.82 | -0.90% | 520.94K | NASDAQ | |||
| 333.28 | 336.10 | 332.00 | -3.23 | -0.96% | 6.15M | NASDAQ | |||
| 2,504.61 | 2,518.66 | 2,496.01 | -22.81 | -0.90% | 576.23K | NASDAQ | |||
| 25.25 | 25.94 | 25.03 | -0.20 | -0.79% | 19.73M | NYSE | |||
| 217.11 | 223.28 | 213.00 | -6.48 | -2.90% | 1.29M | NYSE | |||
| 213.37 | 213.82 | 210.75 | +1.77 | +0.84% | 4.69M | NYSE | |||
| 47.14 | 48.36 | 46.89 | -0.22 | -0.46% | 19.65M | NYSE | |||
| 11.80 | 12.45 | 11.50 | +0.680 | +6.12% | 36.95M | NASDAQ | |||
| 13.35 | 13.87 | 13.22 | -0.16 | -1.18% | 12.27M | NYSE | |||
| 23.72 | 23.80 | 23.22 | -0.29 | -1.21% | 2.16M | NYSE | |||
| 12.81 | 13.44 | 12.58 | +0.25 | +1.99% | 10.79M | NASDAQ | |||
| 17.04 | 17.40 | 16.95 | -0.49 | -2.80% | 1.34M | NASDAQ | |||
| 65.70 | 68.31 | 63.05 | +7.87 | +13.61% | 3.40M | NASDAQ | |||
| 28.46 | 28.63 | 28.41 | -0.28 | -0.97% | 14.80M | NYSE |
Abbott Laboratories Company Profile
Abbott Laboratories Company Profile
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products, including FreeStyle, PediaSure, Pedialyte, Similac, EleCare, ZonePerfect, Juven, Ensure and Glucerna. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. The cardiovascular's products include Portico, MitraClip, Dilatation Catheter, among others. The diagnostics products include IntelliFISH, Vysis ALK, STARLIMS, PathVysion, AlinIQ, among others.
Read More
- 2021-06-15 14:54:53
best time to buy ABT! - 2021-06-01 20:05:38Any idea what is the bottom?
- 2021-06-02 16:41:53
106 but this is long term - 2021-06-02 17:52:10Thank you.. Hope it will holds and does not drop below $100
- 2021-06-01 18:53:03excellent time to buy!!! good company and long run
- 2021-06-01 16:56:05It is time to buy! This is extra money, new business created by Covid. Icing on the cake.
- 2021-05-06 19:37:04
buy now! i think? - 2021-04-19 09:57:20what's the force behind this stock?
- 2021-04-23 15:26:16I don,t
- 2021-05-20 14:48:51
They make Ensure and medical devices - 2021-05-21 05:52:00Black Sheep okie
- 2021-04-12 21:58:55Cổ phiếu sẽ giảm
- 2021-04-09 23:27:53It is only going up. Hate all you want but we are in for the gains. 🤷🏻♂️🤣
- 2021-04-09 16:17:56Best guess before the revenue report: 130$ and then continue going up after.
- 2021-01-28 15:38:29Earnings were Excellent and now the market is adjusting valuation! 🎉🥳 Any guesses since it already covered 2021 goal?
- 2021-01-12 22:05:53Me waiting for that rating change to $250 tomorrow 😣😣😣 Thank you Amen-Ra
- 2021-01-25 18:47:07I wish! Maybe in 5 years
- 2021-01-28 13:28:27I wasnt that far off lol $140 will do
- 2020-12-11 20:39:2925% dividend increase announced today for 2021. Still on the right track I would say. Still holding - on strong!
- 2020-11-12 23:08:37it is good performing here but a bad company to join with staff being squeeze terribly on sales target and no human welfare.
- 2021-01-07 09:50:03Capitalism.
- 2021-01-07 09:50:18Capitalism.
- 2020-11-02 17:02:27This stock is such a good portfolio anchor don't worry about it lagging the earning news. Biden has indicated he wants to expand testing by 7x. A Biden win is a major win for this stock.
- 2020-11-09 14:43:22i agree
- 2020-10-22 12:56:03
Hey Rudy, i am with you. Did not understand this drop. I believe that big investors are sure of the profit due to the covid test and they try to push the price to get more shares to by at least. - 2020-10-21 19:51:53Last earnings in July it jumped up on the earnings beat this time it drops? what is going on? ABT forecast good earnings inclusive of Covid testing for the next few years. I would think that is great news!
- 2020-10-21 19:51:04Last earnings in July it jumped up on the earnings beat this time it drops? what is going on? They forecast good earnings inclusive of Covid testing for the next few years. I would think that is great news!
- 2020-10-21 13:48:05Why is it down???
- 2020-10-20 18:45:38why 127? why not just 115 or 116 or 120. where does 127 come from
- 2020-10-23 16:40:28I think he bouth at 125😅
- 2020-10-19 05:00:00abt will be $127 by the end of the month
- 2020-10-19 04:59:40abt will be $127 by the end of the month
- 2020-10-14 23:38:10
xmm - 2020-10-07 02:47:47
https://www.cbc.ca/news/politics/health-canada-antigen-test-abbott-1.5751939 - 2020-10-05 16:52:50lol 4 thumbs down and my price hit its target. haha you bears. next stop 111-112
- 2020-10-05 10:16:01
Ridiculous market cap for diagnosis corp- 2020-10-06 14:25:08Got like 7 more months of COVID..
- 2020-10-07 16:03:50htf do you figure? covid testing going to be here for years. for herd immunity it will take awhile and the once the vaccine is released another year to distribute. are these fact, no just opinion
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.